Aprotinin protects platelets against the initial effect of cardiopulmonary bypass

Journal of Thoracic and Cardiovascular Surgery

Volumn 99, Issue 5, 1990, Pages 788-797

  Van Oeveren, W ^a   Harder, M P ^a   Roozendaal, K J ^a   Eijsman, L ^a   Wildevuur, C R H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; PLASMIN; THROMBOCYTE RECEPTOR;

ARTICLE; BLEEDING; BLEEDING TIME; CORONARY ARTERY BYPASS SURGERY; DRUG THERAPY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0025271812     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5223(19)36893-x     Document Type: Article

References (27)

1. Wildevuur CRH Towards safer cardiopulmonary bypass Longmore DB Towards safer cardiac surgery 1980 International Medical Publishers Lancaster 293 312
2. Edmunds LH Jr Ellison N Colman RW Platelet function during cardiac operation: comparison of membrane and bubble oxygenators J T horac C ardiovasc S urg 83 1982 805 812
3. Zilla P Fasol R Groscurth P Klepetko W Reichenspurner H Wolner E Blood platelets in cardiopulmonary bypass operations: recovery occurs after initial stimulation, rather than continual activation J T horac C ardiovasc S urg 97 1989 379 388
4. van Oeveren W Kazatchkine MD Descamps-Latscha B Deleterious effects of cardiopulmonary bypass: a prospective study of bubble versus membrane oxygenation J T horac C ardiovasc S urg 89 1985 888 889
5. Musial J Niewiarowski S Hershock D Morinelli TA Colman RW Edmunds LH Jr Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation J Lab Clin Med 105 1985 514 522
6. Wenger RK Lukasiewicz H Mikuta BS Niewiarowski S Edmunds LH Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass J T horac C ardiovasc S urg 97 1989 235 239
7. van Oeveren W Jansen NJG Bidstrup BP Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass Ann Thorac Surg 44 1987 640 645
8. Royston D Bidstrup BP Taylor KM Sapsford RN Effect of aprotinin on need for blood transfusion after repeat open-heart surgery Lancet 2 1987 1289 1291
9. Bidstrup BP Royston D Sapsford RN Taylor KM Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin (Trasylol) J T horac C ardiovasc S urg 97 1989 364 372
10. van Oeveren W Eijsman L Roozendaal KJ Wildevuur CRH Platelet preservation by aprotinin during cardipulmonary bypass Lancet 2 1988 644
11. Harker LA Malpass TW Branson HE Hessel EA II Slichter SJ Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release Blood 56 1980 824 834
12. Salzman EW Weinstein MJ Weintraub RM Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: a double-blind randomized trial N Engl J Med 314 1986 1402 1406
13. Edmunds LH Letter to the Editor concerning: Blood platelets and bypass J T horac C ardiovasc S urg 97 1989 470 477
14. 1 J Lab Clin Med 105 1985 601 607
15. Moncada S Vane JR Arachidonic acid metabolites and the interactions between platelets and blood vessel walls N Engl J Med 300 1979 1142 1149
16. Rådegran K Arén C Teger-Nilsson AC Prostacyclin infusion during extracorporeal circulation for coronary bypass J T horac C ardiovasc S urg 83 1982 205 211
17. Fish KJ Sarnquist FH van Steennis C A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations J T horac C ardiovasc S urg 91 1986 436 442
18. Gluszko P Rucinski B Musial J Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit Am J Physiol 252 1987 H615 H621
19. Meyer D Baumgartner HR Role of von Willebrand factor in platelet adhesion to the subendothelium Br J Haematol 54 1983 1 9
20. Houdyk WP Sakariassen KS Nievelstein PF Sixma JJ Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomenic and fibrillar human collagen types I and III J Clin Invest 75 1985 531 540
21. Sakariassen KS Nievelstein PF Coller BS Sixma JJ The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium Br J Haematol 63 1986 681 691
22. Fressinaud E Baruch D Girma JP Sakariassen KS Baumgartner HR Meyer D Von Willebrand factor–mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb-IIIa as well as glycoprotein Ib J Lab Clin Med 112 1988 58 67
23. De Marco L Girolami A Zimmerman TS Ruggeri ZM Von Willebrand factor interaction with the glycoprotein IIb/IIIa complex: its role in platelet function as demonstrated in patients with congenital afibrinogenemia J Clin Invest 77 1986 1272 1277
24. Dechavanne M French M Pages J Significant reduction in the binding of a monoclonal antibody (LYP 18) directed against the IIb/IIa glycoprotein complex to platelets of patients having undergone extracorporeal circulation Thromb Haemost 57 1987 106 109
25. 1 in patients undergoing clinical cardiopulmonary bypass Ann Thorac Surg 35 1983 406 414
26. Nieuwenhuis HK Akkerman JN Sixma JJ Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients Blood 70 1987 620 623
27. Coller BS A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex J Clin Invest 76 1985 101 108